Printer Friendly

Browse Temozolomide topic

Articles

1-34 out of 34 article(s)
Title Author Type Date Words
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide. Topkan, Erkan; Besen, Ali Ayberk; Ozdemir, Yurday; Kucuk, Ahmet; Mertsoylu, Huseyin; Pehlivan, Berri Jun 30, 2020 5841
Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide. Topkan, Erkan; Besen, Ali A.; Mertsoylu, Huseyin; Kucuk, Ahmet; Pehlivan, Berrin; Selek, Ugur Jun 30, 2020 5829
Efficacy of Temozolomide in Children with Solid Tumors. Ariano, Anna; Attina, Giorgio; Triarico, Silvia; Coccia, Paola; Capozza, Michele Antonio; Mastrangel Report Mar 1, 2020 3408
Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity, and Sensitizes Glioma Cells to Temozolomide. Pang, Dejiang; Li, Chao; Yang, Chengcheng; Zou, Yuanfeng; Feng, Bin; Li, Lixia; Liu, Wentao; Geng, Y Nov 30, 2019 8843
Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells. Zhu, Zhiyuan; Zhang, Pingde; Li, Ning; Kiang, Karrie Mei Yee; Cheng, Stephen Yin; Wong, Vincent Kam- Oct 31, 2019 6513
Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo. Buric, Sonja Stojkovic; Podolski-Renic, Ana; Dinic, Jelena; Stankovic, Tijana; Jovanovic, Mirna; Had Mar 31, 2019 8637
Development and Full Validation of a Stability-indicating HPLC Method for the Determination of the Anticancer Drug Temozolomide in Pharmaceutical Form/Anti-kanser Ilac Temozolomidin Farmasotik Formundan Miktar Tayini icin Ters Faz Sivi Kromatografisi Yonteminin Gelistirilmesi, Validasyonu ve Stabilite Calismasi. Kapcak, Evin; Satana-Kara, Eda Hayriye Report Dec 1, 2018 4296
Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent. Dong, Qian; He, Lin; Chen, Linbo; Deng, Qiongzhen Jan 1, 2018 4655
Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis. Yi, Guo-zhong; Xiang, Wei; Feng, Wen-yan; Chen, Zi-yang; Li, Yao-min; Deng, Sheng-ze; Guo, Man-lan; Jan 1, 2018 5164
In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme. Borhani, Samira; Mozdarani, Hossein; Babalui, Somayyeh; Bakhshandeh, Mohsen; Nosrati, Hassan Report May 1, 2017 4906
Propyl Gallate Exerts an Antimigration Effect on Temozolomide-Treated Malignant Glioma Cells through Inhibition of ROS and the NF-[kappa]B Pathway. Yang, Jen-Tsung; Lee, I-Neng; Lu, Fung-Jou; Chung, Chiu-Yen; Lee, Ming-Hsueh; Cheng, Yu-Ching; Chen, Jan 1, 2017 6562
A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma. Krpan, Ana Misir; Dusek, Tina; Rakusic, Zoran; Solak, Mirsala; Kraljevic, Ivana; Bisof, Vesna; Ozret Report Jan 1, 2017 2639
Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway. Feng, Jun; Yan, Peng-Fei; Zhao, Hong-yang; Zhang, Fang-Cheng; Zhao, Wo-Hua; Feng, Min Report Jan 1, 2017 5781
Mayne Pharma Launches Temozolomide Capsules in U.S. - Generic Alternative to Temodar[R]. Nov 23, 2016 426
Mylan unveils generic Temodar capsules for newly diagnosed cancerous tumors in the US. Jul 11, 2016 161
Lannett wins US FDA approvals for Potassium Chloride Extended-release Capsules USP and Temozolomide Capsules. Mar 30, 2016 200
Lannett wins US FDA approvals for Potassium Chloride Extended-release Capsules USP and Temozolomide Capsules. Mar 30, 2016 196
Lannett passes US FDA approval for chemotherapy agent Temozolomide. Feb 12, 2016 198
Lannett passes US FDA approval for chemotherapy agent Temozolomide. Feb 12, 2016 194
IDT FORMS PARTNERSHIP WITH MAYNE PHARMA. Nov 1, 2015 489
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial. Mao, Ying; Yao, Yu; Zhang, Li-Wei; Lu, Yi-Cheng; Chen, Zhong-Ping; Zhang, Jian-Min; Qi, Song-Tao; Yo Report Oct 20, 2015 4886
US FDA Approves Novocure's Optune Device in Combination with Temozolomide for Glioblastoma. Oct 5, 2015 398
Merck Sharp and Dohme recalls 276,000 bottles with Temodar and Temozolomide capsules. Aug 20, 2015 126
Merck Sharp and Dohme recalls 276,000 bottles with Temodar and Temozolomide capsules. Aug 20, 2015 122
Improved outcomes with intensity modulated radiation therapy combined with temozolomide for newly diagnosed glioblastoma multiforme. Aherne, Noel J.; Benjamin, Linus C.; Horsley, Patrick J.; Silva, Thomaz; Wilcox, Shea; Amalaseelan, Report Jan 1, 2014 3130
Effects of temozolomide in combination with biochanin A on glioblastoma progression. Jain, Aditi; Lai, James C.K.; Bhushan, Alok Abstract Jun 1, 2013 184
Perrigo Company wins Australian approval for generic Temozolomide for malignant glioma. Mar 22, 2012 129
University's anti-cancer drug annual sales pass EUR1 million mark. Feb 12, 2009 220
Optimizing radiotherapy of brain tumours by a combination of temozolomide & lonidamine. Prabhakara, S.; Kalia, V.K. Clinical report Aug 1, 2008 6818
Drug gave our dad precious extra months. Apr 26, 2007 432
Radiotherapy plus temozolomide increases glioblastoma survival. Nov 15, 2004 440
Temozolomide slowed tumors in patients with glioblastoma. Sep 1, 2004 449
Brain Ca Drug Slows Progression of Melanoma. LINDSAY, HEATHER Brief Article Apr 1, 2000 530
Is There Another Blood-Brain Barrier? Fowler, Susan Brief Article Dec 1, 1999 273

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters